Citation Impact
Citing Papers
Guidelines on oral anticoagulation: third edition
1998
Diabetic foot disorders: A clinical practice guideline
2000
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.
2004
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Cutaneous Wound Healing
1999 Standout
The global burden of diabetic foot disease
2005 Standout
Prevention of Deep Vein Thrombosis after Elective Hip Surgery
1991
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Wound healing and its impairment in the diabetic foot
2005 Standout
Chronic Venous Disease
2006 Standout
Analysis of arterial flowmotion in spinal cord injured and elderly subjects in an area at risk for the development of pressure sores
1995
Subcutaneous Heparin Compared with Continuous Intravenous Heparin Administration in the Initial Treatment of Deep Vein Thrombosis
1992
Antithrombotic Therapy for Venous Thromboembolic Disease
1998
Drug-Induced Hepatotoxicity
2003 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Microvascular changes in chronic venous insufficiency—a review
1995
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Microangiopathy of the skin and the effect of leg compression in patients with chronic venous insufficiency
1994
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Mitogenic activity and cytokine levels in non‐healing and healing chronic leg ulcers
2000
Adenosine in Bronchoalveolar Lavage Fluid in Asthma
1993
The frequency histogram—A new method for the evaluation of laser doppler flux motion
1990
The Clinical Course of Pulmonary Embolism
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The role of the distribution and anatomic extent of reflux in the development of signs and symptoms in chronic venous insufficiency
1996
Heparin and Low-Molecular-Weight Heparin
1998
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Diabetic foot ulcers
2003 Standout
The effect of chronic renal failure on drug metabolism and transport
2008
The chronic wound: impaired healing and solutions in the context of wound bed preparation
2003
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism
1995
Safety of Treatment with Oral Anticoagulants in the Elderly
1999
Blood Flow in the Perimalleolar Skin in Relation to Posture in Patients with Venous Hypertension
1989
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Heparin
1991
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Microcirculation of the Diabetic Foot
2005
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial
2007
Preventing Foot Ulcers in Patients With Diabetes
2005 Standout
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)
2013
Polymer/Hemoglobin Assemblies: Biodegradable Oxygen Carriers for Artificial Red Blood Cells
2011
Hemorrhagic Complications of Anticoagulant Treatment
1998
Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
1992
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
1999
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
2002 Standout
The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort
2002 Standout
Enhancement of 5-fluorouracil's anticancer activity by dipyridamole
1989
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin
1991
Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence.
1984
Diabetes and peripheral vascular disease
1999
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Diurnal Rhythm in Anticoagulant Effect of Heparin during a Low Dose Constant Rate Infusion
1992
The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram
1993
Low Molecular Weight Heparin versus Warfarin in the Prevention of Recurrences after Deep Vein Thrombosis
1994
Fiber‐Based Wearable Electronics: A Review of Materials, Fabrication, Devices, and Applications
2014 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients
2006
The relative contributions of antithrombin iii during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.
1987
Prospective 12-Year Follow-up Study of Clinical and Hemodynamic Sequelae After Deep Vein Thrombosis in Low-Risk Patients (Zurich Study)
1996
Differences in Cellular Infiltrate and Extracellular Matrix of Chronic Diabetic and Venous Ulcers Versus Acute Wounds
1998
Heparin and the In-Hospital Management of Deep Venous Thrombosis: Cost Considerations
1986
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique
1974
Use of lightguide spectrophotometry to quantify skin oxygenation in a variable model of venous hypertension
1995
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
2005
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.
1994
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1989
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
The resting interstitial tissue pressure in primary varicose veins
1990
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
1996
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Skin Blood Flow in Chronic Venous Insufficiency
1993
Development of Tolerance to Glyceryl Trinitrate in an Isolated Human Peripheral Vein and Its Relation to Cyclic GMP Metabolism
1986
Low Molecular Weight Heparin versus Acenocoumarol in the Secondary Prophylaxis of Deep Vein Thrombosis
1999
Two Daily Subcutaneous Injections of Fragmin as Compared with Intravenous Standard Heparin in the Treatment of Deep Venous Thrombosis (DVT)
1990
Hemorrhagic Complications of Anticoagulant Treatment
1992
Oxygen Gradients in the Microcirculation
2003
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
1986
Synthetic Approaches to RBC Mimicry and Oxygen Carrier Systems
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Microvascular Changes in Venous Disease: An Update
1997
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Microangiopathy in Severe Chronic Venous Insufficiency Evaluated by Fluorescence Video-Microscopy
1986
Evaluation of a Laser Doppler Flowmeter for Measurement of Tissue Blood Flow
1980
Non-rheumatic atrial fibrillation as a risk factor for stroke.
1985
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
2004
The effect of polyneuropathy on foot microcirculation in Type II diabetes
2002
Microangiopathy in Chronic Venous Insufficiency before and after Sclerotherapy and Compression Treatment: Results of a One-Year Follow-up Study
1993
Combined nitrofurantoin toxicity to liver and lung.
1992
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis
1987
Low-Molecular-Weight Heparins
1997 Standout
Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.
1987
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Hemorrhagic Complications of Anticoagulant Treatment
1995
Treatment of Venous Thromboembolism
1999
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
The Microcirculation in Venous Hypertension
1997
Dermal Neurovascular Dysfunction in Type 2 Diabetes
2001
Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis
1995
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
2014
Home Monitoring of Foot Skin Temperatures to Prevent Ulceration
2004
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers
1986
Antithrombotic Therapy for Venous Thromboembolic Disease
1995
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis
2001
Works of B Fagrell being referenced
Pronounced skin capillary ischemia in the feet of diabetic patients with bad metabolic control
1998
Changes of activated partial thromboplastin time during constant intravenous and fixed intermittent subcutaneous administration of heparin
1989
Discrepancy in Skin Capillary Circulation between Fingers and Toes in Patients with Type 1 Diabetes
1996
Comparison between a New Computerized and an Analogue Videophotometric, Cross-Correlation Technique for Measuring Skin Capillary Blood Cell Velocity in Humans
1994
Local skin pressure and its effects on skin microcirculation as evaluated by laser—Doppler fluxmetry
1989
Skin Capillary Circulation is More Impaired in the Toes of Diabetic Than Non‐diabetic Patients with Peripheral Vascular Disease
1995
Advances in Microcirculation Network Evaluation: an Update
1995
One‐year Sequential Follow‐up of Venous Emptying Rate and Leg Temperature Profiles after Acute Deep Vein Thrombosis
1988
Evaluation of the dynamic cutaneous post‐ischaemic hyperaemia and thermal response in elderly subjects and in an area at risk for pressure sores
1991
Postocclusive reactive hyperemia and thermal response in the skin microcirculation of subjects with spinal cord injury
2020
Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
1999
Vital Capillaroscopy
1972
One‐Month versus Six‐Month Therapy with Oral Anticoagulants after Symptomatic Deep Vein Thrombosis
1985
Relative hematocrit in human skin capillaries and its relation to capillary blood flow velocity
1980
Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine
1984
Disturbed microvascular reactivity and shunting - a major cause for diabetic complications
1999
Vital Capillary Microscopy for Assessment of Skin Viability and Microangiopathy in Patients with Diabetes Mellitus
1984
Subcutaneous administration of heparin a randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis
1982
Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications
1995
A Multicenter Clinical Study of the Safety and Activity of Maleimide-Polyethylene Glycol–modified Hemoglobin (Hemospan®) in Patients Undergoing Major Orthopedic Surgery
2006
Vital capillary microscopy. A clinical method for studying changes of the nutritional skin capillaries in legs with arteriosclerosis obliterans.
1973
Synchronous assessment of human skin microcirculation by laser Doppler flowmetry and dynamic capillaroscopy.
1983
A Nitrofurantoin‐induced Disorder Simulating Chronic Active Hepatitis
1976
Local Microcirculation in Chronic Venous Incompetence and Leg Ulcers
1979
Microcirculatory disturbances - the final cause for venous leg ulcers?
1982
Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications
1995
Vital Capillary Microscopy
1973
Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins
1984
Digital pulse plethysmography and digital blood pressure measurement in the evaluation of arterial circulation in the lower limb.
1973
A microscope-television system for studying flow velocity in human skin capillaries
1977
Vital microscopy and the pathophysiology of deep venous insufficiency.
1995